The optimal time slot selection and feature selection for the prediction of drugs for diseases

[1] M. Aladeemy, S. Tutun and M.T. Khasawneh, A new hybrid approach for feature selection and support vector
machine model selection based on self-adaptive cohort intelligence, Expert Systems with Applications, 88 (2017)
118–131.[2] K. Buzaand and L. Peska, Drug–target interaction prediction with Bipartite Local Models and hubness-aware
regression, Neurocomput. 260 (2017) 284–293.
[3] R. Celebi, O. Erten and M. Dumontier, Machine Learning Based Drug Indication Prediction Using Linked Open
Data, SWAT4LS, 2017.
[4] A.H. Gandomi and A.H. Alavi, Krill herd: a new bio-inspired optimization algorithm, Commun. Nonlinear Sci.
Numerical Simul. 17(12) (2012) 4831–484.
[5] S. Gunasundari, S. Janakiraman and S. Meenambal, Velocity bounded boolean particle swarm optimization for
improved feature selection in liver and kidney disease diagnosis, Expert Systems with Applications, 56 (2016)
28–47.
[6] E. Gundogan and B. Kaya, A link prediction approach for drug recommendation in disease-drug bipartite network,
Artific. Intell. Data Process. Symp. 2017 pp. 1–4.
[7] M.J. Jahid and J. Ruan, An ensemble approach for drug side effect prediction, bioinformatics and biomedicine
(BIBM), 2013 IEEE Int. Conf. IEEE (2013) 440–445.
[8] M.H.M. Lau and J.W. Tenney, Evaluation of drug-disease interactions and their association with unplanned
hospital readmission utilizing STOPP version 2 criteria, Geriatrics 2 (2017) 33.
[9] U. Maulik and D. Chakraborty, Fuzzy preference based feature selection and semisupervised SVM for cancer
classification, IEEE transactions on nanobioscience, 13(2) (2014) 152–160.
[10] H. Moghadam, M. Rahgozar and S. Gharaghani, Scoring multiple features to predict drug disease associations
using information fusion and aggregation, SAR and QSAR in Environmental Research, 27(8) (2016) 609–628.
[11] V. Mudaliar, P. Savaridaasan and S. Garg, Disease prediction and drug recommendation android application using
data mining (virtual doctor), Int. J. Recent Technol. Engin. 8(3) (2019) 6996–7001.
[12] L. Peska, K. Buza and J. Koller, Drug-target interaction prediction: A bayesian ranking approach, Computer
methods and programs in biomedicine, 152 (2017) 15–21.
[13] A. Sharma and R. Rani, BE-DTI’: Ensemble framework for drug target interaction prediction using dimensionality
reduction and active learning, Computer Methods and Programs in Biomedicine, 165 (2018) 151–162.
[14] M.K. Sohrabi and A. Tajik, Multi-objective feature selection for warfarin dose prediction, Computational biology
and chemistry, 69 (2017) 126–133.
[15] F. Viegas, L. Rocha, M. Gon¸calves, F. Mour˜ao, G. S´a, T. Salles, G. Andrade and I. Sandin, A genetic programming
approach for feature selection in highly dimensional skewed data, Neurocomputing, 273 (2018) 554–569.
[16] T. Vivekanandan and N.C.S.N. Iyengar, Optimal feature selection using a modified differential evolution algorithm
and its effectiveness for prediction of heart disease, Computers in biology and medicine, 90 (2017) 125–136.
[17] A.P. Wright, A.T. Wright, A.B. McCoy and D.F. Sittig, The use of sequential pattern mining to predict next
prescribed medications, J. Biomed. Inf. 53 (2015) 73–80.
[18] G. Wu, J. Liu and C. Wang, Predicting drug-disease interactions by semi-supervised graph cut algorithm and
three-layer data integration, BMC Med. Genom. 10(5) (2017) 79.
[19] Y. Yang, Z. Ye, Y. Su, Q. Zhao, X. Li and D. Ouyang, Deep learning for in vitro prediction of pharmaceutical
formulations, Actapharmaceuticasinica B 9(1) (2019) 177–185.
[20] L. Zhang, K. Mistry, C.P. Lim and S.C. Neoh, Feature selection using firefly optimization for classification and
regression models, Decision Support Systems, 106 (2018) 64–85.
[21] D. Zhou, L. Miao and Y. He, Position-aware deep multi-task learning for drug–drug interaction extraction, Artific.
Intell. Med. 87 (2018) 1–8.